• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      NPIL plans acquisition in UK, N. America

      Posted AtSify.com

      Pharmaceutical major, Nicholas Piramal India Ltd (NPIL) on Monday said that the company was looking for acquisition in United Kingdom and North America to expand its overseas operation."We are looking at acquisition in UK and North America," Chairman NPIL, Ajay G Piramal said on the sidelines of India Economic Summit 2005.

      "We are not looking for acquisition to make generic copies of existing drugs but we are interested in process development and manufacturing new molecules through the acquisitions," he said.

      When asked about the market in those countries where the company plans to have a footprint, Piramal said: "We are looking for acquisition to provide drugs in the global market and not just looking at the market in those particular countries." Speaking about the production of Tamiflu drugs, he said: "We are in discussion with Swiss pharma company Roche but talks are at very preliminary stage."

      "Whenever we produce Tamiflu drugs it will not be in conflict with the parent company," he added.

      November 28, 2005


       

      Share this Article!

    Back to top^